JRC releases a new CRM to aid the fight against beta-thalassemia

Our blood is a window to our health. Doctors examine biomarkers in our blood to determine our health status.

Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential

December 12, 2023

Pharmalittle: U.S. selects first 10 drugs for Medicare price negotiations; Pfizer may soon restart tornado-hit plant

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will

August 29, 2023

Internal documents shed new light on Sarepta FDA decision, which top agency official says was ‘exceptional’

While he has repeatedly advocated for accelerated gene therapy approvals, the FDA’s top cell and gene therapy official Peter Marks said that the agency’s landmark

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.